Genus plc

From Wikipedia, the free encyclopedia
Genus plc
TypePublic
Traded as
  • LSE: GNS
  • FTSE 250 component
ISINGB0002074580
IndustryBiotechnology
Founded1933
HeadquartersBasingstoke, Hampshire, UK
Key people
Iain Ferguson, Chairman[1]
Steven Wilson, CEO[1]
RevenueIncrease £574.3 million (2021)[2]
Operating income
Increase £47.7 million (2021)[2]
Net income
Increase £46.8 million (2021)[2]
Websitewww.genusplc.com

Genus plc is a British-based business selling elite genetics and other products manufactured using biotechnology to cattle and pig farmers. It is headquartered in Basingstoke and is a constituent of the FTSE 250 Index.

History[]

The business has its origins in the former Breeding & Production Division of the Milk Marketing Board which was established in 1933 and broken up in 1994.[3] In 1999 Genus acquired ABS Global, a company founded by J.R. Prentice in the US as the American Breeders Service in 1941 selling the semen of cattle.[4] In 2005 Genus acquired, through the takeover of Sygen International plc, PIC, a company founded by six pork producers in the UK as the Pig Improvement Company in 1962.[5]

Operations[]

The Company has three divisions:[6]

  • ABS - products for cattle
  • PIC - products for pigs
  • Genus R&D - management of the research and development pipeline for cattle, pigs and other species.

PIC's pedigree herds sire an estimated 30% of commercially reared pigs.[7]

References[]

  1. ^ a b "Genus plc - Investor Relations - Genus Board". genusplc.com. Archived from the original on 10 July 2017. Retrieved 25 February 2021.
  2. ^ a b c "Annual Report 2021" (PDF). Genus plc. Retrieved 24 February 2022.
  3. ^ The BSE Inquiry Archived 2008-10-10 at the Wayback Machine
  4. ^ "Genus agrees to acquire ABS Global". Milwaukee Business Journal. 3 August 1999. Retrieved 1 March 2020.
  5. ^ "Genus Completes Acquisition Of Sygen". The Pig Site. Archived from the original on 9 February 2012. Retrieved 28 March 2015.
  6. ^ "Genus". Market Watch. Retrieved 25 March 2018.
  7. ^ Devlin, Hannah (20 June 2018). "Scientists genetically engineer pigs immune to costly disease". the Guardian. Retrieved 11 December 2021.

External links[]

Retrieved from ""